38029511000001104: Brolucizumab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1150841000001114 Brolucizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1150851000001112 Brolucizumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brolucizumab	Is a	Substance with Janus kinase inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes	Has specific active ingredient	False	Brolucizumab	Inferred relationship	Existential restriction modifier
Beovu 19.8mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection	Has specific active ingredient	False	Brolucizumab	Inferred relationship	Existential restriction modifier
Beovu 19.8mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	False	Brolucizumab	Inferred relationship	Existential restriction modifier
Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection	Has specific active ingredient	False	Brolucizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets